Efficacy of Transcranial Direct Current Stimulation (tDCS) in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder (ADHD)

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1. 1This trial uses transcranial direct current stimulation — a non-drug brain stimulation technique — instead of medication. Can you help me understand how this approach compares to standard ADHD treatments like stimulant medications, and whether it would make sense for someone at my stage of treatment?
2. 2The trial is listed as 'not yet recruiting,' which means it hasn't started enrolling patients. How might that timing affect my situation if I'm looking for treatment options now — should I be pursuing something else in the meantime?
3. 3The study is measuring changes in inattention symptoms using a self-report scale called the ASRS. Since this is based on self-reporting rather than objective testing, how reliable do you think that outcome measure is for evaluating whether a treatment like tDCS is actually working?
4. 4This trial is listed under Phase NA, which often applies to device or non-drug studies where traditional drug-trial phases don't apply. Does that mean there's less safety and efficacy data available compared to a standard Phase 2 or 3 drug trial, and what does that mean for me as a potential participant?
5. 5If I were eventually eligible and this trial only measures outcomes immediately after the tDCS sessions, how would we know whether any improvement in my inattention symptoms would last over time — and is that something worth asking the study team about before deciding to participate?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.